Skip to content

Combined Use of Radiofrequency-ablation and Balloon-septostomy in the Creation of a Stable Inter-atrial Communication

The Combined Use of Radiofrequency-catheter-ablation and Balloon-atrial-septostomy (CURB) in the Creation of a Stable Inter-atrial Communication:a Preliminary Study in Patients With Pulmonary Arterial Hypertension

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03554330
Acronym
CURB
Enrollment
90
Registered
2018-06-13
Start date
2018-07-12
Completion date
2022-12-30
Last updated
2022-11-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Arterial Hypertension

Keywords

pulmonary arterial hypertension, balloon atrial septostomy, radiofrequency catheter ablation, spontaneous closure

Brief summary

Though graded balloon-atrial-septostomy (BAS) has been accepted as an effective palliative therapy for severe pulmonary arterial hypertension, spontaneous closure of septostomy is not uncommon. Radiofrequency-catheter-ablation (RFA), which has the potential to cause irreversible damage around the rim of created inter-atrial communication, might contribute to prevent the spontaneous closure. In patients with severe pulmonary arterial hypertension, the combined use of RFA and BAS (CURB) is investigated to create a stable inter-atrial communication.

Detailed description

Balloon atrial septostomy (BAS) is an important palliative therapy in patients with refractory pulmonary arterial hypertension. However, the incidence of spontaneous closure is higher, which limits the clinical utilization of this procedure. Radiofrequency catheter ablation (RFA) has the potential to cause irreversible damage around the rim of fenestration created with BAS, which might prevent the re-adhesion of the septal remnants. In addition, RFA on fossae ovalis might reduce the elastic recoil of local tissue and contribute to create larger inter-atrial fenestration with same BAS procedure. In this study, the patients between 18 and 60 years of age who have severe pulmonary arterial hypertension associated with right heart failure refractory to medical therapy or severe syncopal symptoms may be eligible for this study (idiopathic severe pulmonary arterial hypertension or severe pulmonary arterial hypertension associated with repaired congenital heart disease). These patients will be randomized 1:1:1 to control group, single-RFA group and double-RFA group: 1. In control group: only BAS is carried out. 2. In single-RFA group: after BAS procedure identical to control group, RFA is performed immediately around the rim of created inter-atrial fenestration. 3. In double-RFA group: the first step is RFA on fossae ovalis; and then the other two steps are identical to the single-RFA group (BAS and RFA around the rim of fenestration). The immediate size of created fenestration will be determined with intra-cardiac echocardiography, and the patency and size of fenestration will be followed up for 12 months. During the period of follow up, the other evaluations will include the exercise tolerance, cardiac index, systemic arterial oxygen saturation and so on.

Interventions

OTHERRadiofrequency catheter ablation

(1) In control group: only graded balloon atrial septostomy will be carried out and there is no radiofrequency catheter ablation. (2) In single-RFA group: after graded balloon atrial septostomy identical to control group, radiofrequency catheter ablation will be performed immediately around the rim of created inter-atrial fenestration. (3) In double-RFA group: the first step is radiofrequency catheter ablation on fossae ovalis; and then the other two steps are identical to the single-RFA group (BAS and RFA around the rim of fenestration).

OTHERBalloon atrial septostomy

Graded balloon atrial septostomy is performed in all patients.

Sponsors

China National Center for Cardiovascular Diseases
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

1. Idiopathic severe pulmonary arterial hypertension; 2. Severe pulmonary arterial hypertension associated with repaired congenital heart disease; 3. World Health Organization functional class III or IV with right heart failure refractory to medical therapy; 4. Severe syncopal symptoms;

Exclusion criteria

1. Mean right atrial pressure \>20 mm Hg; 2. Room-air resting arterial oxygen saturation \<85%; 3. Left ventricular end diastolic pressure (LVEDP) \>18mm Hg; 4. Pulmonary vascular resistance \>55 wood units/m2. 5. Severe right ventricular failure on cardio-respiratory support 6. The predicted one-year survival \<40%;

Design outcomes

Primary

MeasureTime frameDescription
The size change of the fenestration created with atrial septostomy12 monthsThe changes of the fenestration-size will be followed up in three different groups

Secondary

MeasureTime frameDescription
The exercise tolerance12 months6-min walk test
The systemic arterial oxygen saturation12 monthsThe change of systemic arterial oxygen saturation after atrial septostomy
World Health Organization functional class12 monthsWorld Health Organization functional class before and after atrial septostomy

Countries

China

Contacts

Primary ContactChaowu Yan, PhD and MD
chaowuyan@163.com+8610-88322265

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026